These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20084383)

  • 1. [Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed müllerian tumors. Facts and background].
    Horn LC; Schierle K; Schmidt D; Ulrich U; Liebmann A; Wittekind C
    Pathologe; 2011 May; 32(3):239-43. PubMed ID: 20084383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The 2019 FIGO classification for cervical carcinoma-what's new?].
    Horn LC; Brambs CE; Opitz S; Ulrich UA; Höhn AK
    Pathologe; 2019 Nov; 40(6):629-635. PubMed ID: 31612260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the TNM classification of gynecological tumors].
    Horn LC; Beckmann MW; Beller A; Schmidt D; Ulrich U; Hantschmann P; Wittekind C
    Pathologe; 2010 Sep; 31(5):367-73. PubMed ID: 20844876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
    van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
    Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIGO staging of endometrial cancer: 2023.
    Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
    Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study.
    Semaan A; Mert I; Munkarah AR; Bandyopadhyay S; Mahdi HS; Winer IS; Nucci MR; Hussein Y; Quershi F; Hayek K; Tabassum F; Alosh B; Schultz DS; Cote ML; Vijver KK; Morris RT; Oliva E; Ali-Fehmi R
    Int J Gynecol Pathol; 2013 Mar; 32(2):181-7. PubMed ID: 23370657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO staging of endometrial cancer: 2023.
    Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
    J Gynecol Oncol; 2023 Sep; 34(5):e85. PubMed ID: 37593813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised FIGO staging for carcinoma of the cervix uteri.
    Bhatla N; Berek JS; Cuello Fredes M; Denny LA; Grenman S; Karunaratne K; Kehoe ST; Konishi I; Olawaiye AB; Prat J; Sankaranarayanan R; Brierley J; Mutch D; Querleu D; Cibula D; Quinn M; Botha H; Sigurd L; Rice L; Ryu HS; Ngan H; Mäenpää J; Andrijono A; Purwoto G; Maheshwari A; Bafna UD; Plante M; Natarajan J
    Int J Gynaecol Obstet; 2019 Apr; 145(1):129-135. PubMed ID: 30656645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
    Holm J; Gerke O; Vilstrup MH; Spasojevic D; Sponholtz SE; Jochumsen KM; Thomassen A; Hildebrandt MG; Jensen PT
    Gynecol Oncol; 2022 Nov; 167(2):152-158. PubMed ID: 36182533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
    Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas.
    Karabagli P; Ugras S; Yilmaz BS; Celik C
    Arch Gynecol Obstet; 2015 Aug; 292(2):391-7. PubMed ID: 25608758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current FIGO Staging for Carcinoma of the Cervix Uteri and Treatment of Particular Stages.
    Sehnal B; Kmoníčková E; Sláma J; Tomancová V; Zikán M
    Klin Onkol; 2019; 32(3):224-231. PubMed ID: 31216857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.
    Knoth J; Pötter R; Jürgenliemk-Schulz IM; Haie-Meder C; Fokdal L; Sturdza A; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Wiebe E; Rai B; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Sundset M; Tan LT; Nout RA; Tanderup K; Kirisits C; Nesvacil N; Lindegaard JC; Schmid MP
    Gynecol Oncol; 2020 Oct; 159(1):136-141. PubMed ID: 32798000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of 2009 FIGO staging system on the diagnostic value of preoperative MRI staging of endometrial carcinoma].
    Yu XD; Ouyang H; Lin M; Zhou CW; Zhang R
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):692-6. PubMed ID: 22340052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
    Qin F; Pang H; Yu T; Luo Y; Dong Y
    Technol Cancer Res Treat; 2022; 21():15330338221086403. PubMed ID: 35341413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
    Zhang Y; Ding J; Hua K
    J Int Med Res; 2022 Jan; 50(1):3000605211067397. PubMed ID: 34986672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
    Horn LC; Dallacker M; Bilek K
    Pathologe; 2009 Jul; 30(4):292-301. PubMed ID: 19495763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.